DocGo (DCGO) Competitors $1.28 -0.11 (-7.91%) Closing price 04:00 PM EasternExtended Trading$1.32 +0.04 (+3.52%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DCGO vs. EHAB, TALK, AUNA, INNV, CSTL, FTRE, PSNL, CELC, LFMD, and SBCShould you be buying DocGo stock or one of its competitors? The main competitors of DocGo include Enhabit (EHAB), Talkspace (TALK), Auna (AUNA), InnovAge (INNV), Castle Biosciences (CSTL), Fortrea (FTRE), Personalis (PSNL), Celcuity (CELC), LifeMD (LFMD), and SBC Medical Group (SBC). These companies are all part of the "healthcare" industry. DocGo vs. Enhabit Talkspace Auna InnovAge Castle Biosciences Fortrea Personalis Celcuity LifeMD SBC Medical Group Enhabit (NYSE:EHAB) and DocGo (NASDAQ:DCGO) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability, community ranking and analyst recommendations. Does the media favor EHAB or DCGO? In the previous week, Enhabit and Enhabit both had 15 articles in the media. Enhabit's average media sentiment score of 1.32 beat DocGo's score of 0.75 indicating that Enhabit is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Enhabit 10 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DocGo 6 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of EHAB or DCGO? 56.4% of DocGo shares are held by institutional investors. 1.9% of Enhabit shares are held by insiders. Comparatively, 2.7% of DocGo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Do analysts prefer EHAB or DCGO? Enhabit presently has a consensus target price of $8.50, suggesting a potential downside of 18.32%. DocGo has a consensus target price of $3.56, suggesting a potential upside of 168.68%. Given DocGo's stronger consensus rating and higher possible upside, analysts clearly believe DocGo is more favorable than Enhabit.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Enhabit 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00DocGo 0 Sell rating(s) 3 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is EHAB or DCGO more profitable? DocGo has a net margin of 4.35% compared to Enhabit's net margin of -11.24%. DocGo's return on equity of 8.90% beat Enhabit's return on equity.Company Net Margins Return on Equity Return on Assets Enhabit-11.24% 1.67% 0.80% DocGo 4.35%8.90%5.72% Does the MarketBeat Community believe in EHAB or DCGO? DocGo received 44 more outperform votes than Enhabit when rated by MarketBeat users. Likewise, 73.13% of users gave DocGo an outperform vote while only 17.24% of users gave Enhabit an outperform vote. CompanyUnderperformOutperformEnhabitOutperform Votes517.24%Underperform Votes2482.76% DocGoOutperform Votes4973.13% Underperform Votes1826.87% Which has more risk and volatility, EHAB or DCGO? Enhabit has a beta of 1.61, meaning that its stock price is 61% more volatile than the S&P 500. Comparatively, DocGo has a beta of 1.14, meaning that its stock price is 14% more volatile than the S&P 500. Which has stronger valuation and earnings, EHAB or DCGO? DocGo has lower revenue, but higher earnings than Enhabit. DocGo is trading at a lower price-to-earnings ratio than Enhabit, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnhabit$1.03B0.51-$80.50M-$2.77-3.76DocGo$520.50M0.26$6.86M-$0.02-66.25 SummaryDocGo beats Enhabit on 13 of the 17 factors compared between the two stocks. Get DocGo News Delivered to You Automatically Sign up to receive the latest news and ratings for DCGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DCGO vs. The Competition Export to ExcelMetricDocGoHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$135.13M$845.61M$5.40B$8.53BDividend YieldN/A2.30%5.22%4.11%P/E Ratio4.7353.7826.7419.97Price / Sales0.2610.41394.93122.22Price / Cash23.6226.1438.2534.62Price / Book0.453.926.874.59Net Income$6.86M-$5.50M$3.23B$248.18M7 Day Performance-5.36%7.77%5.01%2.15%1 Month Performance-35.99%71.62%12.82%16.14%1 Year Performance-55.98%19.22%17.63%8.06% DocGo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DCGODocGo3.6871 of 5 stars$1.28-7.9%$3.56+178.1%-54.3%$130.54M$520.50M4.572,920EHABEnhabit2.0795 of 5 stars$10.44+1.5%$8.50-18.5%+18.1%$528.40M$1.03B-4.5010,900News CoveragePositive NewsGap UpTALKTalkspace3.7509 of 5 stars$3.08+2.0%$4.50+46.1%+7.1%$518.79M$194.36M308.31500Positive NewsAUNAAuna3.6725 of 5 stars$6.96+1.4%$13.50+94.1%-17.0%$514.46M$4.39B18.3014,958News CoverageEarnings ReportINNVInnovAge1.0504 of 5 stars$3.80+4.4%$5.00+31.6%-1.6%$513.93M$806.61M-20.002,000Gap UpCSTLCastle Biosciences3.0542 of 5 stars$17.04+1.5%$37.50+120.1%-33.8%$491.98M$347.08M85.20540News CoverageAnalyst ForecastGap UpFTREFortrea3.4043 of 5 stars$5.19-15.6%$15.82+204.8%-82.6%$469.90M$2.70B-1.5218,000Gap DownHigh Trading VolumePSNLPersonalis4.3611 of 5 stars$5.10+1.2%$8.00+56.9%+239.7%$450.37M$84.61M-3.04400News CoverageCELCCelcuity2.1205 of 5 stars$10.68+5.2%$30.17+182.5%-36.6%$404.12MN/A-4.0940Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionLFMDLifeMD1.2695 of 5 stars$8.55+3.5%$11.00+28.7%+34.7%$388.58M$234.01M-13.36230Gap DownSBCSBC Medical GroupN/A$3.46+3.9%N/AN/A$358.49M$205.42M0.00N/AEarnings ReportAnalyst Revision Related Companies and Tools Related Companies EHAB Alternatives TALK Alternatives AUNA Alternatives INNV Alternatives CSTL Alternatives FTRE Alternatives PSNL Alternatives CELC Alternatives LFMD Alternatives SBC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DCGO) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DocGo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.